News | October 25, 2013

Cardiovascular Research Foundation Appoints Jack Lewin as CEO

Healthcare executive takes helm at interventional cardiology foundation

October 25, 2013 — The Cardiovascular Research Foundation (CRF) announced the appointment of John (Jack) Lewin, M.D., as the foundation’s president and CEO. Lewin was also appointed to CRF’s board of directors. CRF believes Lewin brings a unique blend of leadership and management skills to the organization. He succeeds William Himmelsbach, who retired in late 2012. Colette Gardner, CRF board member, served as president and co-chair of the Executive Leadership Council in the interim.
 
“Since its inception in 1990, CRF has played a major role in the great progress that has been made in interventional cardiology, and in realizing dramatic improvements in the lives of countless patients by establishing the safe use of new technologies and therapies for heart disease,” said Lewin. “I look forward to working with CRF’s iconic physicians who are so passionate about advancing the field. The combination of preclinical research, clinical trials and excellence in education under one roof gives the foundation a distinctive ability to generate important research questions, test and refine groundbreaking new therapies, and ensure that these therapies are available to patients at the earliest possible opportunity.”
 
“Jack Lewin’s distinguished background and remarkably innovative tenure as CEO of the American College of Cardiology make him an exceptional individual for this position,” said Eric Woldenberg, chairman, CRF board of directors and senior partner, Pryor Cashman LLP.  “His proven leadership skills, along with his expertise in both the business and clinical aspects of health care, will enable him to help us strengthen and expand our role in the development of new technologies and therapies that will benefit people with heart disease worldwide.” 
 
Lewin served as CEO of the American College of Cardiology (ACC) from 2006 to April 2012. Prior to the ACC, Lewin was CEO of the California Medical Association for eight years. Previously, he was Hawaii’s director of health from 1986-1994, overseeing 6,500 employees, 12 hospitals and a $1 billion budget. Before that, as a commissioned officer in the U.S. Public Health Service, Lewin was the founder and first director of the Navajo Nation Department of Health, serving the needs of America’s largest Indian tribe. He currently serves as the voluntary chairman of the board for the National Coalition on Health Care. In 2011, he was named as one of Modern Healthcare’s 100 most influential people in Healthcare.
 
For more information: www.crf.org
 

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init